A relation between left ventricular (LV) hypertrophy and depressed midwall systolic function has been described in hypertensive subjects. However, a strong confounding factor in this relation is concentric geometry, which is both a powerful determinant of depressed midwall systolic function and a correlate of LV mass in hypertension. To evaluate the independent contribution of LV mass to depressed systolic function, 1827 patients with never-treated essential hypertension (age 48 ؎ 12 years, men 58%) underwent M-mode echocardiography under two-dimensional guidance. Relative wall thickness was the strongest determinant of low midwall fractional shortening (r ‫؍‬ ؊0.63, P < 0.0001). The significant inverse relation observed between LV mass and midwall fractional shortening (r ‫؍‬ ؊0.43, P < 0.0001) persisted after taking into account the effect of relative wall thickness (partial r ‫؍‬ ؊0.27, P < 0.0001).
Introduction
Left ventricular (LV) midwall systolic function has been recently recognised as a more physiological measure of myocardial function than endocardial systolic function. 1, 2 At variance with endocardial indexes, a depressed midwall systolic function has been associated to increased blood pressure load over the 24 hours, 3 and to an adverse prognosis, especially when associated to LV hypertrophy. [4] [5] [6] The difference between the two indexes of LV systolic function is particularly evident in the presence of a markedly concentric LV geometry. In those subjects, endocardial chamber function is almost invariably preserved or even supernormal thanks to their concentric LV geometry, even in the presence of clear-cut abnormalities of midwall function. 7, 8 Several studies showed that midwall systolic Within each sex-specific quintile of relative wall thickness, prevalence of subnormal afterload-corrected midwall systolic function was greater in subjects with, than in subjects without, LV hypertrophy (P < 0.05 for the first, third, fourth and fifth quintile). In a multiple linear regression analysis, both LV mass (P < 0.0001) and relative wall thickness (P < 0.0001) were independent predictors of a reduced midwall fractional shortening. In conclusion, the inverse association between LV mass and midwall systolic function is partly independent from the effect of relative wall thickness. LV hypertrophy is a determinant of subclinical LV dysfunction independently of the concomitant changes in chamber geometry. function is reduced in the presence of LV hypertrophy, and midwall function is able to discriminate subjects with and without LV hypertrophy better than traditional chamber function indexes. 1, [9] [10] [11] However, the strongest correlate of midwall function is LV geometric pattern, concentric geometry (expressed as relative wall thickness) being a powerful determinant of reduced midwall function. 6, 12, 13 A marked increase in relative wall thickness was recently reported in 42 hypertensive patients with depressed LV midwall function compared with 117 hypertensive subjects with normal midwall function, even in the absence of differences in LV mass between the groups. 14 However, the confounding effect of LV geometric pattern on the relation between LV mass and systolic function has never been examined. Thus, the independent relation between LV mass and midwall systolic function in essential hypertension remains to be elucidated. In the setting of the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) study, we had the opportunity to determine LV mass and midwall systolic function, and to examine their independent associations, in a large sample of never-treated subjects with uncomplicated hypertension.
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Subjects and methods
We analysed data of 1827 consecutive subjects with never-treated essential hypertension included in the PIUMA study, whose initial diagnostic work-up included 24-h noninvasive ambulatory blood pressure (BP) monitoring. 3, 15 In the setting of the PIUMA study, a group of general practitioners operating in Umbria, central Italy, referred their hypertensive subjects for baseline off-treatment evaluation to three hospital outpatient clinics (Perugia, Città della Pieve and Castiglione del Lago). All subjects fulfilled the following inclusion criteria: (1) office BP у140/90 mm Hg on у3 visits at 1-week intervals; (2) no previous or current antihypertensive drug treatment; (3) no clinical or laboratory evidence of heart failure, coronary heart disease, previous stroke, valvular defects or secondary causes of hypertension, diabetes, important concomitant disease; and (4) good quality M-mode echocardiography and 24-h BP measurements. A total of 358 patients (16%) had been excluded from the study for poor-quality echocardiograms, and 18 (1%) were excluded for poorquality 24-h BP monitoring. All subjects gave informed consent to the study.
Blood pressure measurement
Office BP was measured by a physician in the hospital outpatient clinic with a mercury sphygmomanometer, with the subject sitting for у10 min. The average of six measurements on у2 sessions was considered for the analysis. Ambulatory BP was recorded using an oscillometric device (models 90202 and 90207, SpaceLabs, Redmond, WA, USA), set to take a reading every 15 min throughout the 24 h. Reading, editing and analysis of data were done as previously described.
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Echocardiography
The M-mode echocardiographic study of the left ventricle was performed under two-dimensional control. Measurements were taken according to the American Society of Echocardiography recommendations. 16 The examinations were performed and read by two authors (GS and PV) who were unaware of patients' clinical data, and the mean value from у5 measurements per observer was computed. LV mass was calculated according to Devereux et al, 17 and normalised by height 2.7 , 18 in order to correct for the effect of overweight. LV hypertrophy was defined as LV mass index у50 g/m 2.7 in men or у47 g/m 2.7 in women. 18 Relative wall thickness was calculated as (2 × posterior wall thickness/LV internal diameter). In our laboratory, the withinobserver test-retest 90% interval of agreement for LV mass measurement is −16 to +14 g ( Figure 1 ). The between-observer test-retest 90% interval of agreement is −20 to +18 g.
LV mechanics was assessed at both the chamber level, as endocardial fractional shortening (FS), and the midwall level, according to a geometric model that takes into account the non-uniform systolic thickening of the LV wall. 1, 19 FS was considered both in absolute terms and after correction for afterload, as a percentage of value predicted from endsystolic circumferential wall stress 19 with regression equations from previously studied normal subjects. 3 We had previously observed that the inverse relation between FS and wall stress was highly significant in both normotensive and hypertensive subjects. 20 The observed-to-predicted FS ratio, called afterload-corrected FS, was used as a measure of myocardial systolic function. Hypertensive subjects were grouped on the basis of their midwall systolic function, according to the difference between observed FS and the value predicted from the above regression equations. Subnormal midwall FS was defined as a midwall FS lower than the 5th percentile of afterload-corrected midwall FS of normotensive subjects. A FS greater than the 5th percentile defined normal midwall systolic function.
Statistical analysis
Hypertensive subjects with and without depressed LV systolic function were compared by Student's ttest for unpaired data. Partial Pearson's correlation coefficients between LV mass index and midwall FS were calculated, keeping relative wall thickness constant. Subjects were ranked by sex-specific quintiles of relative wall thickness. Within each quintile, the linear trend of midwall FS across quintiles of LV mass was tested by one-way analysis of variance, and the prevalence of subnormal midwall function in subjects with and without LV hypertrophy was compared by 2 
Results
Some demographic and clinical characteristics of the study population by presence or absence of LV hypertrophy are reported in Table 1 . Subjects with LV hypertrophy were older, more frequently men and smokers, and had a greater body mass index and higher BP values, both office and 24-h. They also had a more concentric LV geometric pattern and a reduced midwall FS, both in absolute terms and after correction for afterload. Chamber systolic function, assessed through endocardial FS, was slightly reduced in subjects with LV hypertrophy, but the difference was no longer significant after adjustment for afterload.
As expected, a negative correlation was found between LV mass and midwall FS (r = −0.43, P Ͻ 0.0001). However, midwall FS showed a close inverse association to relative wall thickness (r = −0.63, P Ͻ 0.0001), and a significant direct correlation was found between LV mass and relative wall thickness (r = 0.37, P Ͻ 0.0001). After controlling for relative wall thickness, the inverse relation between LV mass and afterload-corrected midwall FS remained statistically significant (partial r = −0.27, P Ͻ 0.0001). 
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Figure 2
In 1827 never-treated hypertensive subjects, left ventricular (LV) midwall fractional shortening decreases progressively by increasing relative wall thickness (from back to front). Within each sex-specific quintile of relative wall thickness, midwall fractional shortening decreases progressively by increasing left ventricular mass (from left to right). All P for trend Ͻ0.001.
When subjects were divided by sex-specific quintiles of LV relative wall thickness (Figure 2 ), midwall FS decreased progressively by increasing relative wall thickness (all P for linear trend Ͻ0.001). Within each quintile, midwall FS decreased progressively by increasing left ventricular mass (all P for linear trend Ͻ0.001). Figure 3 reports the proportion of subjects with depressed afterload-corrected midwall FS in subjects with and without LV hypertrophy. At every given level of relative wall thickness, the prevalence of depressed midwall systolic function was greater in subjects with LV hypertrophy.
The independent contribution of LV mass, relative wall thickness and several other demographic, anthropometric and haemodynamic variables to LV midwall systolic function was tested in a stepwise multiple linear regression. Relative wall thickness (P Ͻ 0.0001), LV mass (P Ͻ 0.0001), cigarette smoking (P Ͻ 0.004), and advancing age (P Ͻ 0.02) were independent predictors of a reduced midwall FS, while body weight was associated to a greater midwall FS (P Ͻ 0.002). 
Discussion
The main finding of the present paper is that, in a large population of subjects with uncomplicated, never-treated essential hypertension, LV mass shows an independent inverse relation with myocardial systolic function. This relation remained significant after adjustment for several confounding variables including LV geometric pattern.
Previous studies
It had been previously observed that LV midwall function may be depressed in subjects with a markedly concentric LV geometry, and endocardial chamber function is almost invariably preserved or even supernormal in these subjects thanks to their concentric LV geometry, which maximizes endocardial shortening for any given level of midwall shortening. 7, 8 Thus, midwall FS identifies a reduced myocardial systolic function in a large subgroup of hypertensive subjects, 3 whose chamber function is still preserved thanks to their more concentric LV geometry. 7, 8 Some previously published work 1,9-11 indicates that when midwall FS is used, myocardial contractile function is often depressed in hypertensive hypertrophy in the presence of a normal endocardial shortening. However, in essential hypertension LV hypertrophy tends to be associated to a more concentric LV geometric pattern (r = 0.37 between LV mass and relative wall thickness in our population), and the confounding effect of LV geometry was not taken into account in those papers. Thus, despite the use of the more physiologic midwall mechanics indexes, the independent relation between LV hypertrophy and systolic function remains unproven in humans.
Present study
Our data confirm that LV relative wall thickness is the strongest determinant of midwall FS. In the present population of never-treated subjects with essential hypertension, however, there was an inverse correlation between LV mass and midwall systolic function, which remained significant also after adjustment for the powerful confounding effect of concentric LV geometry. For every given value of relative wall thickness, the proportion of subjects with subnormal afterload-corrected myocardial function was greater in the presence than in the absence of LV hypertrophy (Figure 3 ). In the presence of an identical chamber geometry, midwall FS progressively decreases with increasing LV mass values (Figure 2 ). All subjects were free from concomitant overt cardiovascular disease and diabetes mellitus, which may have an independent influence on LV mass and function. 21 We also excluded the potential confounding effect of current or previous antihypertensive treatment.
The present findings support the role of LV hypertrophy as a determinant of depressed myocardial function in never-treated subjects with uncomplicated hypertension, but do not provide a mechanism to explain these results. Afterload-corrected analyses indicate that increased afterload does not appear to be responsible for the observed reduction in shortening, which might be due to chronically decreased fibre length 1, 22 or a depressed inotropic state. Several experimental data may offer a pathological explanation of our findings. Increasing LV mass in rat hearts 23 and pressure overload in human atria 24 are strongly related to an enhanced ␤-myosin heavy chain gene expression, a phenotype that is associated to a reduced velocity of myocardial contraction. In experimental animals, longstanding hypertension induces LV remodelling due to regression of hypertrophic myocytes and replacement fibrosis followed by LV dilation. 25 The transition from a state of compensation to myocardial failure is related to both cardiomyocyte loss 26 and alterations in the metabolism of extracellular matrix. 27 In humans, LV hypertrophy is accompanied by a nearly two-fold increase in myocardial interstitium; 28 moreover, there is in vivo evidence of myocardial cell damage in subjects with advanced LV hypertrophy and symptomatic hypertensive heart disease. 29 Cross-sectional associations are to be taken with caution, though, and we are aware that our present cross-sectional findings might be compatible with exactly opposite interpretations, eg that a reduced myocardial contractility, acting through an increase in chamber size, can be responsible for an increase in LV mass. 30 
Clinical implications
The present findings of an independent association between LV mass and a decline in myocardial performance have several potential clinical implications. Hypertension is the most common risk factor for congestive heart failure in the general population, 31 and the risk is further increased in subjects with electrocardiographic 31, 32 or echocardiographic 33 evidence of LV hypertrophy. Our results demonstrate a biological interaction between LV mass and subclinical systolic dysfunction at a preclinical stage of the hypertensive disease, which may contribute in part to the high risk of heart failure to which subjects with LV hypertrophy are exposed. [31] [32] [33] Identification of early, subclinical LV systolic dysfunction might be of prognostic importance in hypertension, [4] [5] [6] though data are still lacking on the specific role of reduced midwall FS as a predictor of heart failure in humans. In this regard, an important role in the development of LV hypertrophy and failure in hypertension has been attributed to the renin-angiotensin system activation. In hypertensive rats, sub-hypotensive doses of angiotensin II receptor blockers and angiotensinconverting enzyme inhibitors are able to prevent LV maladaptive responses, including excessive myocyte hypertrophy, interstitial fibrosis and heart failure. 34 In humans, angiotensin-converting enzyme inhibitors were shown to be significantly more effective than calcium-channel blockers, and marginally more than diuretics and ␤-blockers, in prevention of congestive heart failure in elderly hypertensive patients. 35 There is some evidence that regression of LV hypertrophy induced by antihypertensive treatment is accompanied by an improvement in midwall systolic function, [36] [37] [38] even in the absence of concomitant changes in LV geometry. 37 Further studies are needed to demonstrate whether treatment-induced regression of LV hypertrophy, and the possibly associated improvement in myocardial function, [36] [37] [38] might lead to a more effective prevention of heart failure in essential hypertension.
